[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Kelly K. Hunt<\/i><\/u><\/presenter>. UT MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"6a2a63de-f2d3-4406-bfb0-39c52f5477a7","ControlNumber":"7620","DisclosureBlock":"&nbsp;<b>&nbsp;K.K. Hunt:<\/b>  ; ArmadaHealth. ; AstraZeneca. ; Cairn Surgical. ; Eli Lilly and Company. ; Lumicell.","End":"4\/8\/2024 12:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"378","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Kelly Hunt, MD","PresenterKey":"100202b6-150c-4573-bd0d-0992ca7fab42","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024 12:30PM","SessionId":"138","SessionOnDemand":"False","SessionTitle":"Neoadjuvant Therapies","ShowChatLink":"false","Start":"4\/8\/2024 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Kelly K. Hunt<\/i><\/u><\/presenter>. UT MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"b0a84f06-a9f3-4f4e-a269-b28b57c67372","ControlNumber":"8951","DisclosureBlock":"<b>&nbsp;K. K. Hunt, <\/b> <br><b>ArmadaHealth<\/b> I. <br><b>AstraZeneca<\/b> I. <br><b>Cairn Surgical<\/b> G. <br><b>Eli Lilly and Company<\/b> G. <br><b>Lumicell<\/b> G.","End":"4\/8\/2024 12:35:00 PM","HasWebcast":null,"Highlights":[],"Id":"398","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Kelly Hunt, MD","PresenterKey":"100202b6-150c-4573-bd0d-0992ca7fab42","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Introduction","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024 12:30PM","SessionId":"138","SessionOnDemand":"False","SessionTitle":"Neoadjuvant Therapies","ShowChatLink":"false","Start":"4\/8\/2024 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Kelly K. Hunt<\/i><\/u><\/presenter>. UT MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"8dfcb4f6-2e12-4891-ba41-c4d2e8b77178","ControlNumber":"9034","DisclosureBlock":"<b>&nbsp;K. K. Hunt, <\/b> <br><b>ArmadaHealth<\/b> I. <br><b>AstraZeneca<\/b> I. <br><b>Cairn Surgical<\/b> G. <br><b>Eli Lilly and Company<\/b> G. <br><b>Lumicell<\/b> G.","End":"4\/8\/2024 12:55:00 PM","HasWebcast":null,"Highlights":[],"Id":"481","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Kelly Hunt, MD","PresenterKey":"100202b6-150c-4573-bd0d-0992ca7fab42","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Neoadjuvant therapy in breast cancer: Endpoints, targets and future directions","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024 12:30PM","SessionId":"138","SessionOnDemand":"False","SessionTitle":"Neoadjuvant Therapies","ShowChatLink":"false","Start":"4\/8\/2024 12:35:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Neoadjuvant therapy in breast cancer: Endpoints, targets and future directions","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"85d1f4da-99ce-45ec-b95e-80139452c2f7","ControlNumber":"10640","DisclosureBlock":"","End":"4\/8\/2024 1:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"8167","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024 12:30PM","SessionId":"138","SessionOnDemand":"False","SessionTitle":"Neoadjuvant Therapies","ShowChatLink":"false","Start":"4\/8\/2024 12:55:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"Neoadjuvant therapy, the delivery of systemic therapy and\/or radiation before the primary course of treatment has been primarily used as a strategy to improve the ability to completely resect the tumor, treat clinically occult metastatic disease, determine pathologic treatment effects, and possibly add to prognostic information. With the introduction of immune checkpoint inhibitor (ICI) therapy, which inhibits T cell-negative co-stimulation in order to generate antitumor T-cell responses that recognize tumor antigens, another possible advantage to neoadjuvant ICI therapy has been recognized in that having abundant antigen by leaving the tumor in place can augment anti-tumor responses to ICI therapy. Indeed, data from RCTs in melanoma now support a survival benefit for neoadjuvant ICI therapy over adjuvant therapy. In this presentation, we will review melanoma clinical trial data, the shift for using this approach as standard practice, unanswered questions, and future directions.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":"++CL11-03 Surgical outcomes after neoadjuvant therapy,,"},{"Key":"Keywords","Value":"Immune checkpoint,Surgical resection,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Georgia Beasley<\/i><\/u><\/presenter>. Duke University, Durham, NC","CSlideId":"","ControlKey":"5ec18cb0-68ed-4960-be56-dd035e9f5189","ControlNumber":"9035","DisclosureBlock":"<b>&nbsp;G. Beasley, <\/b> <br><b>Bristol Myers Squibb Company<\/b> I. <br><b>Delcath<\/b> I. <br><b>Replimune<\/b> I.","End":"4\/8\/2024 1:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"482","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Georgia Beasley, MD;MHS","PresenterKey":"7c66d091-d9e8-4c7f-bf52-90a61f5a4a8a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Getting a head start with neoadjuvant therapy in melanoma","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024 12:30PM","SessionId":"138","SessionOnDemand":"False","SessionTitle":"Neoadjuvant Therapies","ShowChatLink":"false","Start":"4\/8\/2024 1:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Getting a head start with neoadjuvant therapy in melanoma","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"e33054b7-c52a-48a8-ab04-4c58df4a10f6","ControlNumber":"10641","DisclosureBlock":"","End":"4\/8\/2024 1:25:00 PM","HasWebcast":null,"Highlights":[],"Id":"8168","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024 12:30PM","SessionId":"138","SessionOnDemand":"False","SessionTitle":"Neoadjuvant Therapies","ShowChatLink":"false","Start":"4\/8\/2024 1:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Jonathan C. Trent<\/i><\/u><\/presenter>. University of Miami, Miami, FL","CSlideId":"","ControlKey":"2ff2ca9b-3ad4-43ef-804f-4dac558f88b1","ControlNumber":"9036","DisclosureBlock":"&nbsp;<b>J. C. Trent, <\/b> None.","End":"4\/8\/2024 1:45:00 PM","HasWebcast":null,"Highlights":[],"Id":"483","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Jonathan Trent, MD, PhD","PresenterKey":"f4466404-c02f-4f08-9572-19363f027d66","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Progress in neoadjuvant therapy for soft-tissue sarcoma","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024 12:30PM","SessionId":"138","SessionOnDemand":"False","SessionTitle":"Neoadjuvant Therapies","ShowChatLink":"false","Start":"4\/8\/2024 1:25:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Progress in neoadjuvant therapy for soft-tissue sarcoma","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"be3ab5a3-6d04-42e4-a5dd-8dac9de7e568","ControlNumber":"10642","DisclosureBlock":"","End":"4\/8\/2024 1:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"8169","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024 12:30PM","SessionId":"138","SessionOnDemand":"False","SessionTitle":"Neoadjuvant Therapies","ShowChatLink":"false","Start":"4\/8\/2024 1:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"d0e18cb2-f62d-4416-98f1-03ec33174c8c","ControlNumber":"10643","DisclosureBlock":"","End":"4\/8\/2024 2:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"8170","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"General Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024 12:30PM","SessionId":"138","SessionOnDemand":"False","SessionTitle":"Neoadjuvant Therapies","ShowChatLink":"false","Start":"4\/8\/2024 1:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"General Discussion","Topics":null,"cSlideId":""}]